Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PsCatCh2.0 is an engineered, light-sensitive cation channel derived from the green alga Platymonas subcordiformis, optimized for high light sensitivity and rapid kinetics (Bionic Sight, 2021). It is the therapeutic transgene utilized in optogenetic gene therapy, such as BS01, aimed at restoring vision in patients with advanced retinal degenerative diseases like retinitis pigmentosa (ClinicalTrials.gov, NCT04278131). When expressed in retinal ganglion cells (RGCs) via an adeno-associated virus (AAV) vector, PsCatCh2.0 allows these cells to bypass the degenerate photoreceptor layer and respond directly to light (Nirenberg & Pandarinath, 2012). Upon activation by specific wavelengths, the channel facilitates the influx of cations, primarily sodium and calcium, leading to neuronal depolarization and the transmission of visual information to the brain (Mager et al., 2018). This approach is intended to work in conjunction with an external wearable device that captures visual scenes and projects optimized light patterns onto the retina to provide high-resolution visual restoration. The high sensitivity of PsCatCh2.0 is a critical feature, as it enables the restoration of visual function under ambient light conditions or with lower-intensity stimulation from external devices.
Light-activated cation channel that induces depolarization in retinal ganglion cells to restore visual signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platymonas subcordiformis Calcium-transmitting Channelrhodopsin 2.0 (PsCatCh2.0) (PsCatCh2.0).